Company Filing History:
1 out of 29 
1 out of 669 
Years Active: 2016
Title: Niccolo Bartalucci: Innovator in Cancer Therapy
Introduction
Niccolo Bartalucci is a prominent inventor based in Florence, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of combination therapies. His work focuses on the intersection of JAK kinase inhibitors and dual PI3K/mTOR inhibitors, which are crucial in the fight against various cancers.
Latest Patents
Bartalucci holds a patent for a combination therapy titled "JAK PI3K/mTOR combination therapy." This patent outlines a method that combines a JAK kinase inhibitor with a dual PI3K/mTOR inhibitor. The therapy aims to provide effective treatment options for patients suffering from different types of cancer.
Career Highlights
Throughout his career, Niccolo Bartalucci has worked with leading pharmaceutical companies, including Novartis Pharma AG and Incyte Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer therapy.
Collaborations
Bartalucci has collaborated with notable professionals in the field, including Alessandro M. Vannucchi and Costanza Bogani. These partnerships have contributed to the advancement of his research and the successful development of his patented therapies.
Conclusion
Niccolo Bartalucci is a key figure in the realm of cancer treatment innovation. His dedication to developing effective therapies showcases the importance of collaboration and research in the medical field. His contributions continue to impact the lives of many patients facing cancer.